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Summary
Background and Objectives: Few studies have been conducted in pediatric
patients evaluating efficacy of prophylactic antibiotics for prevention of surgi-
cal site infection (SSI). This retrospective study was undertaken to determine
the effect of antibiotic prophylaxis in the prevention of SSI in children.
Methods: With IRB approval, our perioperative electronic clinical informa-
tion database was queried. Pediatric patients (≤18 years) undergoing general
surgery, cardiac surgery, and spinal surgery at Mott Children’s Hospital from
January 2000 to April 2010 were included. Demographics and preoperative
data were obtained from the Centricity Intraoperative Database, and any
episodes of SSI were obtained by review of the infection control records.
Results: A total 5023 pediatric patients underwent surgery from January
2000 to April 2010. The average age of the children in the sample was
4.16  5.5 years, and of these, 57% were boys. Overall, 119 (2.37%) cases of
SSI were identified. There were no associations between the various patient
factors and the development of SSIs. Children for whom antibiotics were
administered incorrectly had a 1.7-fold increased risk of SSIs compared with
children who received antibiotics within the recommended guidelines
(P < 0.02). Children who received antibiotics were more likely to suffer an
SSI compared with those who did not.
Conclusions: Proper administration of preoperative antibiotics in pediatric
patients is one of the few modifiable and significant factors in prevention of
SSI.
Introduction
Surgical site infection (SSI) accounts for 14–16% of
nosocomial infections in the United States (1). SSI
adds greatly to the cost of hospitalization and
increases morbidity and mortality (2). In the pediatric
population, it has been shown to increase hospital stay
by 10.6 days and increase the cost of hospitalization
by $27 000 (3). The incidence of SSIs in the pediatric
population ranges from 2.5% to 20% (4–10). Current
guidelines define appropriate antibiotic prophylaxis for
SSI as administration within 60 min prior to incision
(11). Although antibiotic prophylaxis given within 1 h
of surgical incision has been shown to be effective in
preventing surgical infections in breast, appendix, and
colorectal surgery in adults (2), there have been few
studies regarding the efficacy of this prophylactic
guideline for antibiotics administration for prevention
of SSI in children. Currently, prophylactic antibiotic
guidelines exist for certain subsets of the pediatric sur-
gical population, but there are no global recommenda-
tions, and the guidelines that exist are mostly based
on studies from adults or from expert opinion
(1,11,12).
© 2014 John Wiley & Sons Ltd
Pediatric Anesthesia 24 (2014) 994–998
994
Pediatric Anesthesia ISSN 1155-5645
In one study, Horwitz et al. examined risk factors for
wound infection in children and found that preoperative
antibiotics did not influence the development of SSI.
However, there was no attempt to standardize the types
of antibiotics used or the overall duration of therapy,
making it difficult to make conclusions regarding the
efficacy of prophylactic antibiotics on SSI reduction (8).
Another study conducted by Porras-Hernandez et al.
examined risk factors for SSI in a pediatric hospital and
found that antibiotic prophylaxis was marginally signifi-
cant as a protective factor. However, the power of this
study was low and multivariate analysis was not per-
formed, and furthermore, there was an unusually high
baseline infection rate of 18.7% (13). In another study,
Bucher et al. (14) examined risk factors and outcomes in
children who developed SSI and determined that antibi-
otic administration was not an independent predictor of
SSI. Most recently, Hawn et al. evaluated the timing of
antibiotic prophylaxis using data from the National Vet-
erans Affairs Database and concluded that SSI risk fac-
tors were associated with patient and procedure factors,
but not with antibiotic prophylaxis timing (15).
To date, no study has specifically sought to answer
the direct impact of prophylactic antibiotics on SSI
development in children. This retrospective study there-
fore was undertaken to evaluate whether appropriate
antibiotic prophylaxis, within 60 min prior to incision
and appropriate dosage, is associated with a reduction
in SSIs in children undergoing a variety of surgical
procedures.
Materials and methods
With institutional review board approval, the periopera-
tive electronic clinical information database (Centricity
General Electric Healthcare, Waukesha, Wisconsin) was
queried to identify pediatric patients who underwent
surgery at CS Mott Children’s Hospital from July 2008
to April 2010. All pediatric patients (age 18 or younger)
undergoing general surgery, cardiac surgery, or spinal
surgery were included. Additionally, cardiac surgery
cases from January 2000 to April 2010 and spinal sur-
gery cases from January 2006 to April 2010 were
included. Patient demographics and preoperative data
including age, gender, surgical procedure, and presence
of comorbidities (i.e., upper respiratory tract infections,
malignancy, and diabetes) were obtained from the Cen-
tricity Perioperative Database. Details regarding the
administration of antibiotics were also recorded. Failure
to administer antibiotics correctly was defined as admin-
istration greater than 1 h prior to surgical incision, after
surgical incision, or administration of a dose below the
recommended weight per kilogram guidelines as defined
by the University of Michigan’s antibiotic prophylaxis
guidelines for pediatric patients. At our institution,
Infection Control and Epidemiology follows all cases
after surgery for at least 30 days to monitor for develop-
ment of SSI and documents these. These records are
extracted from the examined.
Infection Control and Epidemiology staff evaluated
all patients for SSIs who underwent surgery at CS Mott
Children’s Hospital operating rooms per protocol set by
the Infection Control and Epidemiology Department.
All SSI were determined using CDC/NHSN definitions.
The cases of SSI development were monitored, and data
were collected. Additionally, medical records of patients
who underwent surgery were queried to identify any SSI
that may not have been cultured for organisms. The key-
words used to identify possible SSI included: redness,
red, surgical site infection, wound infection, wound
infected, wound vacuum assisted closure, wound
packing, wound packed, open wound, incision, deep,
superficial, debride, dehisce, osteomyelitis, mastitis,
endometritis, endocarditis, mediastinitis, meningitis,
perforation, ventriculitis, leak, sinusitis, cellulitis, fascia,
eviscer purulent, purulence, draining, drainage, abscess,
culture, erythema, tender, swelling, swollen, infect,
stitch, warm, fever, hematoma, itis, pus, seroma, yellow,
brown, inflame, white, malodorous, smell, open, fluid,
serous, and serosanguinous.
Statistical analysis
Statistical analyses were performed using SPSS statisti-
cal software (v18.0 IBM Corp, New York, NY, USA).
Descriptive data were analyzed using frequency distribu-
tions. Correlations between variables were calculated
using Spearman’s rho correlation coefficient. Chi-square
analysis with Fisher’s exact test was used to examine
relationships between various independent variables and
the dependent outcome variable of surgical site infec-
tion. Odds ratios with 95% confidence intervals were
also calculated. Based on the adult data, factors that
were found to be associated with the development of
SSI were subsequently entered into a logistic regression
model to identify independent predictors of infection.
Data are presented as n (%). Statistical significance was
accepted at the 5% level (P < 0.05).
Results
A total 5023 pediatric patients who underwent surgery
from January 2000 to April 2010 were included in the
study. The average age of the children in the sample was
4.16  5.5 years, and of these, 57% were boys. Overall,
119 (2.37%) cases of SSI were identified. Table 1
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describes the demographics of the sample by case type,
American Society of Anesthesiologists physical status,
and age and shows that the frequency of SSI was similar
regardless of the site of surgery.
Table 2 describes the association between various
patient factors and the development of SSIs. As shown,
there were no associations between the various patient
factors and the development of SSIs although children
with diabetes were almost six times more likely to expe-
rience an SSI compared with nondiabetic children.
However, although this association appears clinically
significant, it did not reach statistical significance, likely
due to the small number of patients with diabetes.
Table 3 describes the effect of antibiotic administration
and correct timing on the development of SSI. Children
for whom antibiotics were administered incorrectly had
a 1.7-fold increased risk of SSIs compared with children
who received antibiotics within the recommended guide-
lines. Interestingly, children who received correctly
timed and dosed antibiotics were more likely to suffer
an SSI compared with those who did not.
Risk factors included in the logistic regression model
were based on prior adult studies (1–3,5,13,16) and
included the following: gender, ASA status, tobacco
use/exposure, respiratory infection, diabetes, lung
disease, use of corticosteroids, malignancy, correct anti-
biotic dose, and time of antibiotic administration.
Results identified both incorrect dosing and antibiotic
administration as independent risk factors for SSIs in
this sample of children.
Table 1 Demographics
Surgical case type Cases
Cardiac surgery 3104 (61.8)
Neonate (≤30 days) 436 (14.0)
Infant (>30 days, ≤1 year) 827 (26.6)
Child (>1 year, ≤12 years) 1212 (39.0)
Adolescent (>12 years, ≤18 years) 629 (20.3)
ASA ≤2 855 (27.5)
ASA ≥3 2249 (72.5)
Developed SSI 72 (2.32)
Spinal/neurosurgery 338 (6.7)
Neonate (≤30 days) 51 (15.2)
Infant (>30 days, ≤1 year) 115 (34.0)
Child (>1 year, ≤12 years) 138 (40.8)
Adolescent (>12 years, ≤18 years) 34 (10.2
ASA ≤2 91 (26.9)
ASA ≥3 247 (73.1
Developed SSI 8 (2.37)
General surgery 1581 (31.5)
Neonate (≤30 days) 357 (22.6)
Infant (>30 days, ≤1 year) 602 (38.1)
Child (>1 year, ≤12 years) 543 (34.3)
Adolescent (>12 years, ≤18 years) 79 (5.0)
ASA ≤2 420 (26.6)
ASA ≥3 1161 (73.4)
Developed SSI 39 (2.47)
Data are expressed as n (%) SSI = surgical site infection,
ASA = American Society of Anesthesiologists physical status.
Table 2 SSI factors evaluated
Characteristics*
Non-SSI
N = 4904
SSI
N = 119 OR (95% CI)
Sex
Male 2798 (97.7) 67 (2.3) 1.03 (0.70–1.51)
Female 2106 (97.7) 52 (2.4)
ASA score
ASA ≤2 1338 (97.5) 34 (2.5) 0.94 (0.62–1.43)
ASA ≥3 3566 (97.7) 85 (2.3)
ASA emergency
Yes 492 (97.2) 14 (2.8) 1.2 (0.65–2.16)
No 4412 (97.7) 105 (2.3)
Tobacco exposure
Yes 61 (98.4) 1 (1.6) 0.67 (0.03–4.54)
No 4842 (97.6) 118 (2.4)
Upper respiratory infection
Yes 102 (100) 0 (0.0) 0.00 (0.00–1.93)
No 4801 (97.6) 119 (2.4)
Lung disease
Yes 486 (97.4) 13 (2.6) 1.12 (0.60–2.05)
No 4418 (97.7) 106 (2.3)
Malignancy
Yes 57 (98.3) 1 (1.7) 0.72 (0.04–4.87)
No 4847 (97.6) 118 (2.4)
Diabetes
Yes 7 (87.5) 1 (12.5) 5.92 (0.27–48.2)
No 4891 (97.6) 118 (2.4)
Renal disease
Yes 186 (97.9) 4 (2.1) 0.88 (0.27–2.51)
No 4718 (97.6) 115 (2.4)
Data are presented as n (%), OR, odds ratio; CI, confidence intervals;
SSI, surgical site infection.
*Characteristics from history obtained by anesthesia provider and
documented in preoperative evaluation.
Table 3 Antibiotic administration
Non-SSI SSI OR (95% CI)
Incorrect antibiotic administration**
Yes 814 (96.4) 30 (3.6) 1.70 (1.09, 2.63)*
No 4090 (97.9) 89 (2.1)
ABX given
Yes 3654 (97.1) 108 (2.9) 3.36 (1.75, 6.62)*
No 1250 (99.1) 11 (0.9)
ABX, antibiotic; OR, odds ratio; CI, confidence intervals; SSI, surgical
site infection.
*P < 0.02.
**Incorrect antibiotic administration correctly is defined as adminis-
tering either greater than 1 h prior to surgical incision, after surgical
incision, or administering dose below recommended guidelines.
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Discussion
This retrospective study was designed to specifically
look at the effect of antibiotic prophylaxis in the preven-
tion of SSI in pediatric patients. The overall rate of SSI
in our study was 2.37%, which is consistent with the
findings of others (4–10). Although studies suggest asso-
ciations between different factors and the development
of SSIs, only a few potential factors can actually be
modified to help prevent these infections. According to
Bucher et al. (14), postoperative location, urinary cathe-
ter insertion, and use of an implantable device are
potentially modifiable risk factors for an SSI in children.
Results from this study also suggest that the appropriate
use of antibiotic prophylaxis is another vital modifiable
risk factor and may be the easiest factor to influence.
Indeed, our study found that primary failure to adminis-
ter the correct dose of antibiotics resulted in an almost
twofold increase in the risk of developing an SSI
(included in incorrect dosing was one case of early
administration and one case of late administration of
antibiotics). However, children who received an antibi-
otic had a greater likelihood of developing an SSI com-
pared with children who did not receive antibiotic
prophylaxis. The reasons for this are unclear; however,
this may simply reflect the fact that the children who did
not receive a prophylactic antibiotic were undergoing
procedures for which there was no indication and thus
were perceived to be at lower risk for SSI. Indeed, the
children in our study who did not receive an antibiotic
but developed an SSI were older compared with children
who did receive a preoperative antibiotic (8.0  7.0 vs
3.5  5.5 years) and were likely healthier (ASA IV: 0%
vs 50.9%, respectively) and thus at lower baseline risk.
Additionally, we did not break down wound classifica-
tion, although a majority was class I wound type given
the large sample size of cardiac surgery cases. This may
also play a predominant role. Additionally, it is possible
that some patients did not receive antibiotics because
they were already on an appropriate antibiotic regimen
and thus prophylactic administration was not
warranted.
Recently, emphasis has been placed on the presurgical
incision administration of antibiotics to reduce SSI, with
reimbursement being tied to proper administration of
antibiotics prior to surgery (16). Several recent studies
have begun to evaluate Medicare regarding pay for per-
formance measures and outcomes including SSI
(15,17,18). Nicholas et al. recently examined, in a retro-
spective manner, the measures between hospital compli-
ance with surgical care reported on the Hospital
Compare website and adverse outcomes. These authors
concluded that the lower end compliance hospitals had
similar risk-adjusted outcomes on adverse events,
including SSI (18). However, questions arise whether
reimbursement should be tied to outcomes which have
yet to show a correlation with improved outcomes for
patients (19). To date, there are few studies that have
attempted to look at risk factors for SSI in the pediatric
population, more specifically, the role of antibiotic pro-
phylaxis. This is the first study, to our knowledge, to
demonstrate the importance of appropriate antibiotic
administration in children as a means to reduce SSI. The
importance of correct antibiotic usage and dosing plays
a major role in decreasing risk of SSI in children.
There are several limitations to our study. First, this
study was performed retrospectively at a large, single,
tertiary care center. As such, these results may not be
generalizable to other institutions whose patient popula-
tion and medical practice vary. A large population of
our sample included cardiac surgery patients and gen-
eral surgery on neonates leading to high number of
patients classified as ASA 4. Second, patients who devel-
oped SSI may have been missed if they were discharged
home or developed SSI after discharge from hospital
and were followed primarily in a clinic or an outside
facility. This could lead to an underestimate of actual
number of SSI cases. Third, our study did not look at all
factors, some of which have been shown to increase the
risk of SSI such as placement of indwelling catheters,
admission after surgery, placement of an implantable
device, and core temperature during surgery due to
information availability from our perioperative data-
base. Furthermore, a lack of standardized protocol at
our institution regarding choice of antibiotic makes it
difficult to access proper decisions. Antibiotic shortages
at certain times may have also played a role in altering
antibiotic choices. In addition, perhaps patients had an
antibiotic allergy preventing use of specific antibiotics,
which was not evaluated in this study. Also, we did not
breakdown wound classification as a factor. While a
majority of cases were class I because of the large sample
size of cardiac and spine surgeries, there was a large
amount of missing data from general surgery cases,
making it difficult to use this as a factor for analysis.
Additionally, this study encompassed 10 years, during
which the protocol for antibiotic prophylaxis changed
to range-based dosing rounded to a common number
for children over 2.5 kg instead of a strict milligram per
kilogram dosing. Finally, although the sample size was
based on a large convenience sample, we recognize
that it may have been insufficiently powered for some
analyses.
Results of this study reinforce the importance of cor-
rect preoperative antibiotic prophylaxis for the preven-
tion of SSIs in children. Although the results of previous
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studies have been somewhat equivocal, this is the first
study to our knowledge showing that failure to provide
proper antibiotic prophylaxis increases the risk of SSI in
a large group of children. Although there may be several
factors that contribute to the development of SSIs, the
results of this study suggest that administration of anti-
biotics in a timely and correct fashion for children is
both modifiable and effective. Larger prospective studies
are needed to look specifically at timing of antibiotics as
well as choice of antibiotics in prevention of SSI as well
as other modifiable risk factors.
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